- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/625 - Acide salicyliqueSes dérivés ayant des substituants hétérocycliques, p. ex. 4-salicyloylmorpholine
Détention brevets de la classe A61K 31/625
Brevets de cette classe: 46
Historique des publications depuis 10 ans
|
3
|
4
|
6
|
4
|
5
|
1
|
5
|
3
|
5
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Allergan Holdings Unlimited Company | 41 |
3 |
| Smith & Nephew, Inc. | 2687 |
3 |
| Techfields Pharma Co., Ltd. | 30 |
3 |
| Eli Lilly and Company | 3726 |
2 |
| Romark Laboratories L.C. | 55 |
2 |
| Sun Pharmaceutical Industries Limited | 759 |
2 |
| The Regents of the University of California | 19544 |
1 |
| University of Florida Research Foundation, Inc. | 3962 |
1 |
| Allergan Pharmaceuticals International Limited | 241 |
1 |
| Cornell University | 3205 |
1 |
| Euticals S.p.A. | 11 |
1 |
| The George Washington University | 425 |
1 |
| The Governing Council of The University of Toronto, | 1429 |
1 |
| Hutecs Korea Pharmaceutical Co. Ltd | 3 |
1 |
| Indiana University Research and Technology Corporation | 800 |
1 |
| Kangwon National University Industry Cooperation Foundation | 23 |
1 |
| L. PERRIGO Company | 60 |
1 |
| Lupin Limited | 442 |
1 |
| Michigan State University | 79 |
1 |
| New England Medical Center Hospitals, Inc. | 14 |
1 |
| Autres propriétaires | 17 |